Douglas J. Swirsky - 14 Jun 2024 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLRB	Stock option (right to buy)	Award	$0	+90,000		$0.000000	90,000	14 Jun 2024	Common Stock	90,000	$2.58	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This option was contingently granted on December 22, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024.
F2	This option shall vest in full on December 22, 2024, subject to the reporting person's continued service through the applicable vesting date.